{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-134571","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.203204+00:00","generated_at":"2026-06-16T00:21:42.233525+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Globus Medical, NuVasive get FTC second request for merger; Q3 2023 close expected","bullets":["FTC issued Second Request on May 3, 2023, extending HSR waiting period for the merger.","Both companies received requisite stockholder approvals at April 27, 2023 meetings.","Merger expected to close in Q3 2023, subject to HSR clearance and other conditions.","Globus and NuVasive are cooperating with FTC to satisfy the Second Request."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-134571","json":"https://secwatch.observer/filing/0001193125-23-134571.json","markdown":"https://secwatch.observer/filing/0001193125-23-134571.md","text":"https://secwatch.observer/filing/0001193125-23-134571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/0001193125-23-134571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000119312523134571/d352462d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T00:21:42.233525+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}